previou
studi
demonstr
oral
immun
use
autographa
californica
baculoviru
drive
express
gallectin
fragment
entamoeba
histolytica
confer
protect
ala
develop
hamster
studi
determin
abil
protect
ala
intramuscular
rout
well
liver
immun
respons
associ
protect
result
show
hamster
im
immun
show
steril
protect
ala
wherea
show
reduct
size
extent
abscess
result
protect
anim
compar
sham
control
group
level
protect
show
linear
correl
develop
intens
specif
antiamoeba
cellular
humor
respons
evalu
serum
spleen
hamster
respect
evalu
cytokin
pattern
express
liver
hamster
show
steril
protect
associ
product
high
level
ifn
result
suggest
baculoviru
system
equal
effici
intramuscular
well
oral
rout
ala
protect
gallectin
fragment
highli
protect
antigen
hepat
amoebiasi
local
induct
ifn
entamoeba
histolytica
protozoan
parasit
caus
amoebiasi
human
diseas
wide
preval
popul
develop
countri
poor
live
condit
hygien
parasit
estim
infect
million
peopl
around
world
although
real
number
e
histolytica
case
unknown
due
inclus
estim
case
morpholog
ident
e
dispar
e
moshkovskii
speci
howev
sinc
e
histolytica
uniqu
speci
consid
pathogen
human
appear
respons
million
case
amoeb
dysenteryamoeb
liver
abscess
death
everi
year
mexico
amoebiasi
rank
sixth
highest
caus
morbid
incid
case
per
habit
amoebiasi
treatment
reli
use
imidazol
deriv
metronidazol
highli
effect
drawback
induc
side
effect
mutagen
high
concentr
induc
develop
cellular
resist
thu
report
vitro
induct
resist
cultur
high
concentr
metronidazol
continu
exposur
increas
concentr
drug
well
descript
patient
amoeb
biom
research
intern
liver
abscess
reluct
treatment
anoth
option
shuffl
control
amoebiasi
develop
vaccin
regard
mani
trial
immun
experiment
anim
use
differ
amoeba
antigen
combin
adjuv
galactosebind
lectin
among
antigen
commonli
use
protect
assay
protein
complex
three
subunit
prefer
locat
surfac
parasit
whose
main
compon
heavi
subunit
kda
also
one
immunogen
e
histolytica
molecul
along
protein
famili
serinerich
protein
kda
cysteinerich
alkyl
hydroperoxid
reductas
gallectin
consid
one
main
target
effect
vaccin
amoebiasi
gallectin
cysteinerich
portion
kda
lectin
subunit
target
serum
patient
amoeb
liver
abscess
well
igg
iga
antigallectin
antibodi
recov
serum
fece
patient
intestin
amoebiasi
respect
oral
nasal
immun
mice
gerbil
nonhuman
primat
cysteinrich
section
galactoseinhibit
lectin
cholera
toxin
adjuv
induc
high
level
specif
serum
igg
fecal
iga
antibodi
inhibit
vitro
e
histolytica
adher
cho
cell
moreov
intraperiton
immun
gerbil
fragment
titermax
adjuv
elicit
igg
antibodi
confer
protect
ala
recent
demonstr
one
main
target
antibodi
elicit
natur
infect
femal
baboon
e
histolytica
thu
anim
show
serum
igg
iga
antibodi
respect
exhibit
fecal
secretori
iga
antibodi
noteworthi
specif
recognit
epitop
nativ
gallectin
infect
baboon
similar
specif
recognit
human
asymptomat
subject
ala
patient
although
promis
result
obtain
protect
assay
amoebiasi
use
variou
experiment
model
mice
hamster
gerbil
use
strategi
protect
human
futur
hamper
use
adjuv
potenti
toxic
proinflammatori
mammal
bacteri
toxin
oilbas
adjuv
previou
report
propos
use
viral
vector
baculoviru
strategi
deliveri
amoeb
antigen
studi
protect
baculovirus
insect
virus
capabl
infect
mammalian
cell
replic
promis
autographa
californica
envelop
doublestrand
dna
nucleopolyhedroviru
drive
express
foreign
gene
mammalian
cell
without
caus
cytotox
effect
viru
abil
transduc
wide
rang
mammalian
cell
includ
liver
kidney
cell
therefor
propos
deliveri
vector
human
gene
therapi
mainli
oncolyt
agent
sens
californica
propos
tool
target
transfer
therapeut
gene
carcinoma
cell
patient
prostat
colorect
lung
cancer
well
amelior
collater
ischaemia
organ
transplant
noteworthi
nonhuman
viru
speci
preclin
studi
californica
classifi
categori
neglig
regard
rel
environment
risk
suggest
use
human
medic
purpos
includ
gene
therapi
vaccin
safe
vaccin
deliveri
strategi
baculoviru
californica
advantag
prime
immun
respons
innat
adapt
well
humor
cellular
prevent
need
adjuv
potenti
advers
effect
bacteri
toxin
oilbas
formula
thu
baculoviru
display
target
antigen
surfac
andor
drive
express
control
cytomegaloviru
promot
highli
effici
induc
immun
respons
confer
protect
viral
parasit
infect
experiment
model
previou
report
describ
potenti
californica
nucleopolyhedroviru
acnpv
system
drive
express
e
histolytica
gallectin
fragment
confer
steril
partial
protect
ala
oral
nasal
immun
hamster
although
protect
associ
develop
antiamoeb
cellular
immun
respons
measur
spleen
underli
cytokin
cell
popul
respons
identifi
herein
complement
previou
studi
evalu
potenti
intramuscular
immun
acnpvcmvgallectin
system
confer
protect
ala
hamster
determin
whether
rout
immun
confer
greater
level
protect
mucos
deliveri
evalu
liver
local
produc
cytokin
cell
popul
respons
protect
axen
imss
trophozoit
maintain
medium
supplement
adult
bovin
serum
biofluid
intern
inc
md
usa
diamond
vitamin
mix
jrh
bioscienc
kansa
usa
trophozoit
virul
maintain
success
passag
hamster
liver
insect
cell
spodoptera
frugiperda
invitrogen
san
diego
ca
cultiv
suspens
grace
medium
invitrogen
usa
supplement
heat
inactiv
fetal
bovin
serum
invitrogen
carlsbad
ca
penicillinstreptomycin
uml
pluron
invitrogen
usa
baculoviru
product
describ
recombin
baculoviru
amplifi
infect
insect
cell
multipl
infect
moi
purifi
cultur
supernat
day
concentr
ultracentrifug
resuspend
pb
titer
use
plaqu
assay
follow
manufactur
instruct
invitrogen
usa
male
syrian
golden
hamster
mesocricetu
auratu
week
age
maintain
free
pathogen
water
food
ad
libitum
follow
protocol
approv
institut
anim
care
committe
anim
divid
group
hamster
acnpvwt
group
group
hamster
sham
group
hamster
group
acnpvwt
intramuscularli
immun
three
dose
twoweek
interv
pfu
wildtyp
recombin
baculoviru
prepar
l
pb
ph
respect
sham
group
receiv
l
pb
intramuscular
rout
follow
protocol
two
week
last
immun
anim
infect
intraport
rout
virul
e
histolytica
trophozoit
brief
hamster
anesthet
sodium
pentobarbit
mgkg
anestes
pfizer
laparatomi
practic
asept
condit
trophozoit
l
pb
directli
inject
portal
vein
site
inject
immedi
obtrud
appli
gel
foam
pad
intestin
care
return
abdomin
caviti
abdomin
layer
sutur
surgic
stapl
reflex
usa
blood
sampl
collect
anim
treatment
immun
prior
challeng
sera
obtain
centrifug
store
c
use
elisa
well
plate
coat
overnight
ng
well
trophozoit
total
extract
carbon
buffer
ph
c
block
bsatween
hamster
sera
dilut
bsa
ad
well
incub
h
c
extens
wash
pbstween
hrpconjug
antihamst
igg
antibodi
becton
dickinson
usa
ad
dilut
incub
h
c
well
wash
antigenantibodi
complex
develop
opd
read
nm
spectrophotomet
cytokin
determin
perform
solubl
liver
extract
hamster
commerci
avail
mous
ifn
elisa
max
standard
kit
biolegend
accord
manufactur
instruct
captur
elisa
cytokin
assay
perform
triplic
time
brief
liver
extract
obtain
sonic
three
time
sec
ice
tissu
fragment
contain
ala
diluent
solut
provid
kit
presenc
complet
proteas
inhibitor
cocktail
roch
extract
centrifug
rpm
min
c
solubl
fraction
determin
protein
concentr
lowri
method
store
c
use
cytokin
determin
well
ad
g
extract
l
diluent
solut
incub
h
room
temperatur
secondari
antibodi
use
dilut
diluent
solut
h
room
temperatur
immun
complex
develop
use
avidinehrptmb
substrat
read
nm
spectrophotomet
sacrific
day
challeng
hamster
spleen
remov
cellular
fraction
obtain
perfus
ml
supplement
rpmi
medium
cell
incub
hemolysi
solut
wash
centrifug
rpmi
media
erythrocyt
lysi
lymphocyt
gate
ml
bsa
solut
incub
mmml
cfse
celltrac
cfse
cell
prolifer
kit
invitrogen
min
c
incub
cell
wash
rpmi
media
cultiv
plate
c
co
humid
h
rpmi
medium
alon
stimul
concanavalin
gwell
ameb
total
extract
gwell
final
lymphocyt
harvest
fix
formaldehyd
solut
treatment
carri
triplic
anim
sampl
analyz
facscanto
ii
flow
cytomet
bd
minimum
event
use
diva
softwar
comput
analysi
carri
facsdiva
softwar
version
statist
analysi
perform
batch
analysi
report
prolifer
data
experiment
group
obtain
pool
mean
triplic
anim
present
mean
sd
assay
liver
function
blood
sampl
obtain
hamster
day
sacrific
serum
separ
blood
sampl
centrifug
rpm
min
room
temperatur
serum
marker
liver
function
alanin
amino
transferas
alt
determin
method
eagleuv
depart
patholog
faculti
veterinari
medicin
unam
comparison
infect
rate
done
use
fisher
exact
test
kruskalw
test
use
compar
antibodi
prolifer
lymphocyt
group
valu
consid
statist
signific
analys
statist
analys
perform
use
spss
statist
softwar
version
order
evalu
potenti
recombin
baculoviru
drive
express
amoeb
gallectin
fragment
protect
ala
hamster
intramuscularli
immun
viral
particl
intraport
challeng
virul
e
histolytica
trophozoit
descript
recombin
baculovirus
obtain
evalu
drive
express
gallectin
fragment
previous
report
compar
macroscop
descript
liver
show
variabl
grade
ala
develop
figur
massiv
develop
ala
extend
throughout
liver
observ
nonimmun
challeng
hamster
sham
group
figur
e
f
tabl
contrast
develop
ala
variabl
immun
challeng
anim
thu
hamster
immun
recombin
baculoviru
immun
wildtyp
baculoviru
show
gross
figur
b
microscop
evid
shown
ala
develop
suggest
intramuscular
immun
baculoviru
per
se
capabl
give
steril
protect
increas
twice
immun
recombin
baculoviru
tabl
moreov
within
immun
anim
develop
ala
anim
immun
wild
viru
immun
show
partial
protect
tabl
show
millimetr
abscess
scatter
throughout
liver
figur
c
larg
abscess
usual
locat
one
lobe
figur
protect
develop
ala
confirm
analyz
hepatomegali
associ
test
liver
function
particular
determin
alanin
aminotransferas
alt
pyridox
cytoplasm
phosphatedepend
enzym
involv
cellular
nitrogen
metabol
amino
metabol
acid
liver
gluconeogenesi
alt
level
often
low
blood
increas
case
liver
diseas
event
includ
damag
tissu
result
show
high
level
alt
three
time
refer
valu
serum
nonimmun
infect
anim
sham
group
correl
increas
twice
weight
liver
result
abscess
tabl
contrast
liver
weight
alt
level
serum
immun
anim
correl
degre
protect
normal
valu
hamster
fulli
protect
alt
ul
liver
around
g
intermedi
anim
show
partial
protect
tabl
overal
consid
hamster
immun
recombin
baculoviru
versu
wt
group
fisher
test
hamster
immun
wild
baculoviru
versu
group
fisher
test
show
evid
protect
develop
ala
tabl
analysi
sera
hamster
elisa
whole
amoeba
antigen
show
develop
high
level
specif
igg
antibodi
intramuscular
immun
recombin
baculovirus
figur
white
bar
versu
control
group
sinc
sera
anim
immun
wild
baculoviru
well
sham
control
anim
show
reaction
antigen
amoeba
antibodi
hyperimmun
sera
immun
hamster
assum
direct
fragment
gallectin
figur
respons
hamster
antigen
specif
prolifer
lymphocyt
determin
sensit
spleen
cell
hamster
incub
splenocyt
presenc
whole
amoeba
antigen
result
show
level
prolifer
correl
degre
protect
obtain
recombin
baculoviru
figur
greater
immun
anim
protect
entir
rate
follow
partial
protect
rate
figur
c
versu
group
prolifer
immun
protect
hamster
twice
anim
control
group
statist
differ
contrast
anim
protect
even
total
partial
protect
immun
wild
baculoviru
show
degre
splenocyt
prolifer
whole
amoeba
antigen
figur
order
identifi
solubl
element
local
cellular
immun
respons
associ
protect
obtain
ala
ifn
associ
cytokin
extract
liver
protect
hamster
evalu
result
anim
immun
complet
protect
averag
ifn
infect
anim
pgml
versu
pgml
almost
twice
level
partial
protect
hamster
statist
signific
figur
similarli
statist
differ
ifn
level
liver
partial
protect
nonprotect
anim
way
trend
observ
acnpvwt
group
total
protect
anim
time
averag
ifn
infect
anim
pgml
versu
pgml
figur
twice
respect
anim
show
partial
protect
final
differ
group
observ
cytokin
data
shown
respect
cytokin
profil
differ
observ
level
data
shown
ifn
averag
higher
liver
anim
fulli
protect
compar
immun
infect
anim
pgml
versu
pgml
figur
b
way
partial
protect
hamster
show
tendenc
higher
concentr
infect
differ
statist
signific
regard
acnpvwt
immun
group
total
protect
anim
show
six
time
higher
infect
anim
previou
studi
demonstr
potenti
californica
nucleopolyhedroviru
acnpv
drive
express
e
histolytica
gallectin
fragment
confer
steril
partial
protect
ala
oral
nasal
immun
hamster
underli
cytokin
cell
popul
respons
identifi
report
aim
determin
whether
intramuscular
immun
hamster
recombin
baculoviru
abl
confer
greater
level
protect
mucos
vaccin
develop
ala
follow
intraport
challeng
virul
amoeb
trophozoit
whether
protect
correl
particular
type
local
immun
respons
result
show
intramuscular
immun
hamster
recombin
baculoviru
confer
overal
level
protect
similar
previous
obtain
oral
rout
versu
resp
moreov
steril
protect
level
obtain
rout
also
similar
oral
versu
intramuscular
result
unexpect
ala
system
type
infect
probabl
intramuscular
rout
immun
higher
effici
induc
system
protect
respons
oral
rout
therefor
support
propos
group
other
oral
rout
may
appropri
administ
vaccin
amoebiasi
gener
addit
classic
advantag
rout
manag
noninvas
need
special
personnel
oral
rout
trigger
local
system
immun
respons
addit
confer
protect
intestin
amoebiasi
may
also
protect
develop
liver
abscess
trophozoit
manag
pass
intestin
liver
noteworthi
extraintestin
amoebiasi
particular
ala
consid
main
caus
human
death
e
histolytica
effect
gallectin
vaccin
amoebiasi
extens
studi
recent
new
model
intestin
infect
e
histolytica
baboon
papio
sp
efficaci
nasal
vaccin
amoeb
coliti
use
gallectin
synthet
peptid
report
notabl
vaccin
schedul
four
dose
g
peptidenostril
combin
cholera
toxin
adjuv
week
abl
erad
amoeb
infect
baboon
day
intracec
challeng
trophozoit
moreov
serum
igg
iga
antibodi
induc
natur
infect
baboon
e
histolytica
direct
epitop
present
fragment
gallectin
immunodomin
share
human
carri
asymptomat
e
histolytica
infect
recent
cure
ala
result
togeth
obtain
group
previous
report
use
recombin
baculovirus
drive
express
fragment
well
protect
assay
use
immunogen
highli
support
gallectin
particular
fragment
target
protect
antibodi
cellular
immun
respons
resolv
intraand
extraintestin
amoebiasi
therefor
basic
compon
effect
vaccin
human
amoebiasi
immun
element
respons
protect
intestin
amebiasi
ala
entir
known
studi
found
associ
steril
protect
ala
local
product
high
level
ifn
cytokin
profil
result
agreement
previou
studi
protect
ala
hamster
correl
product
cytokin
protect
assay
use
ehcpadh
surfac
complex
immunogen
addit
relev
ifn
play
role
innat
immun
ala
came
studi
scid
mice
target
disrupt
ifn
receptor
gene
moreov
cell
deriv
ifn
also
essenti
protect
intestin
amoebiasi
murin
model
vaccin
recombin
leca
fragment
gallectin
determin
adopt
cell
transfer
ifn
neutral
assay
sourc
protect
ifn
assay
unknown
could
cell
respond
specif
amoeba
antigen
observ
cell
prolifer
assay
best
protect
anim
show
higher
respons
amoeba
extract
howev
nkt
cell
sourc
earli
product
ifn
liver
ala
also
well
known
regard
interestingli
wildtyp
baculoviru
abl
confer
protect
also
associ
local
product
high
level
ifn
suggest
activ
innat
immun
respons
baculoviru
probabl
ifn
local
nkt
cell
partli
respons
observ
protect
thu
demonstr
baculoviru
recognit
lead
product
variou
cytokin
trigger
innat
immun
includ
ifn
turn
potenti
confer
high
level
protect
sever
experiment
model
influenza
intranas
immun
wildtyp
baculoviru
protect
mice
lethal
challeng
report
correl
partial
steril
protect
ala
local
product
high
level
also
observ
figur
b
although
product
associ
suscept
intestin
infect
amoeba
previou
studi
group
use
lactoferrin
oral
therapi
treatment
intestin
amebiasi
mice
show
product
cytokin
tissu
ceca
anim
cure
suggest
paper
like
product
result
feedback
mechan
control
excess
inflamm
typic
featur
intestin
mous
liver
hamster
amoebiasi
restor
physiolog
antiinflammatori
state
predomin
intestin
liver
also
augment
fibroblast
growth
collagen
product
granuloma
format
characterist
mark
chronic
develop
ala
reaction
tri
contain
infect
thu
possibl
role
depend
whether
liver
abscess
develop
contribut
format
granuloma
later
stage
ala
develop
decreas
excess
inflamm
earlier
stage
protect
ala
hamster
also
associ
induct
serum
antiamoeb
antibodi
particularli
igg
figur
consist
varieti
previou
studi
demonstr
antibodi
import
protect
amoeba
particularli
secretori
iga
intestin
amebiasi
serum
igg
iga
hepat
amoebiasi
possibl
high
level
ifn
observ
protect
hamster
also
contribut
increas
product
igg
antibodi
mention
mainli
isotyp
respons
link
two
arm
immun
respons
liver
infect
e
histolytica
taken
togeth
result
suggest
respons
cellular
humor
fragment
gallectin
import
develop
resist
hamster
ala
immun
human
alway
face
difficulti
identifi
safe
adjuv
gener
unwant
side
effect
protect
assay
intestin
andor
liver
amoebiasi
describ
use
toxin
deriv
bacteria
miner
veget
oil
suspens
although
induc
good
immun
respons
also
usual
gener
local
system
inflammatori
respons
implic
health
vaccin
subject
work
reinforc
probabl
use
recombin
baculoviru
system
altern
approach
use
toxic
adjuv
safe
releas
amoeba
antigen
mammal
due
per
se
capac
stimul
innat
immun
respons
thu
condit
gener
specif
antiamoeba
adapt
immun
respons
sens
mani
studi
demonstr
phenotyp
function
matur
dendrit
cell
macrophag
well
direct
activ
b
cell
induc
acnpv
result
antigen
present
respons
report
noteworthi
accept
use
baculoviru
human
recent
increas
ongo
trial
gene
therapi
base
use
virus
deliveri
system
lay
foundat
safe
extend
use
recombin
baculoviru
system
area
vaccin
final
studi
cell
adopt
transfer
neutral
cytokin
ifn
probabl
need
determin
mechan
underli
protect
ala
baculovirusimmun
hamster
well
immun
studi
use
anim
model
closer
human
primat
order
determin
safeti
effect
system
view
use
strategi
vaccin
amoebiasi
human
